Published in
Elsevier, Journal of The American Academy of Dermatology, 5(83), p. 1367-1374, 2020
DOI: 10.1016/j.jaad.2020.05.105
Links
Tools
Bimekizumab for patients with moderate-to-severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled phase 2b extension study
Journal article published in 2020 by
Andrew Blauvelt,
Kim A. Papp,
Joseph F. Merola 
,
Alice B. Gottlieb,
Nancy Cross,
Cynthia Madden,
Maggie Wang,
Christopher Cioffi,
Christopher E. M. Griffiths
,
Alice B. Gottlieb,
Nancy Cross,
Cynthia Madden,
Maggie Wang,
Christopher Cioffi,
Christopher E. M. Griffiths
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 